Low back pain (LBP) has been a substantial and consistent driver of medical utilization and cost for WEA Trust. It is also a significant concern for WEA Trust’s employer groups given its impact on employment costs and productivity. WEA Trust partnered with Kiio to proactively intervene with easy, convenient, and evidence-based digital musculoskeletal (MSK) therapy care for medically appropriate members struggling with back pain.
Kiio, white-labeled to WEA Trust, launched in January 2018 and is offered to all members regardless of LBP claims history. Health plan members enroll on a completely voluntary basis.
Prior to enrolling, interested members complete Kiio’s online screening to gather baselines and confirm medical appropriateness. Members who are ineligible to participate for medical or other reasons are directed to appropriate in-network care as part of Kiio’s customized Care Path Optimization(SM). Eligible members are provided immediate access to Kiio’s digital MSK care program, which includes three progressive levels of therapeutic exercise specific to the member’s type of LBP, pain education, virtual coaching, and unlimited access to 1:1 Care Team support.
In this study, WEA Trust and Kiio collaborated to quantify Kiio’s impact on member outcomes, medical and pharmacy utilization, and cost of care. The large, longitudinal study compared a year’s worth of claims from Kiio participants (N=656) to a control group receiving traditional MSK care for LBP (N=23,709). For Kiio participants, 12 months of claims were assessed after their enrollment date in Kiio, and for those receiving traditional care, 12 months of claims were assessed starting with their first LBP claim. All data was then normalized to member months.